These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9009442)

  • 1. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS).
    de la Rubia J; Carral A; Montes H; Urquijo JJ; Sanz GF; Sanz MA
    Haematologica; 1996; 81(6):536-9. PubMed ID: 9009442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
    Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
    Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
    Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
    Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease.
    Smith FO; Johnson MS; Scherer LR; Faught P; Breitfeld PP; Albright E; Hillier SC; Gowan D; Smith PD; Robertson KA; Emanuel D
    Bone Marrow Transplant; 1996 Sep; 18(3):643-6. PubMed ID: 8879632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
    Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
    Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
    Fried MW; Connaghan DG; Sharma S; Martin LG; Devine S; Holland K; Zuckerman A; Kaufman S; Wingard J; Boyer TD
    Hepatology; 1996 Sep; 24(3):588-91. PubMed ID: 8781329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS for veno-occlusive disease following stem cell transplantation.
    Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
    Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
    Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
    Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
    Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver.
    Fisher DC; Vredenburgh JJ; Petros WP; Hussein A; Berry DA; Elkordy M; Rubin P; Gilbert CJ; Peters WP
    Bone Marrow Transplant; 1998 Jan; 21(2):117-22. PubMed ID: 9489626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.
    Campos-Varela I; Castells L; Dopazo C; Pérez-Lafuente M; Allende H; Len O; Llopart L; Vargas V; Charco R
    Liver Transpl; 2012 Feb; 18(2):201-5. PubMed ID: 21656652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
    Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
    Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Veno-occlusive disease--an important complication in hematopoietic cells transplantation].
    Skotnicki AB; Krawczyk J
    Przegl Lek; 2001; 58(11):995-9. PubMed ID: 11987843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.
    Kalayoglu-Besisik S; Yenerel MN; Caliskan Y; Ozturk S; Besisik F; Sargin D
    Transplant Proc; 2005 Jun; 37(5):2285-9. PubMed ID: 15964400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis.
    Silva RF; Arroyo PC; Duca WJ; Silva AA; Reis LF; Cabral CM; Sgnolf A; Domingues RB; Barao GT; Coelho DJ; Deberaldini M; Felício HC; Silva RC
    Transplant Proc; 2004 May; 36(4):926-8. PubMed ID: 15194319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current role of portosystemic shunt surgery in the management of hepatic venous outflow obstruction.
    Singhal D; de Castro S; Goyal N; Gouma DJ; Chaudhary A; van Gulik TM
    Dig Surg; 2006; 23(5-6):358-69. PubMed ID: 17164547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.